Crawford & (CRD-B) Q2 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure
Key numbers
- Reported EPS
- $0.38
- Estimate
- $0.28
- Surprise
- +35.7%
- Revenue (period 2026-06-30)
- $330.0M
- Score today
- 5.5/10
Revenue source: xbrl.
How the report landed
Crawford & (CRD-B) beat the $0.28 estimate with diluted EPS of $0.38 — a large 35.7% upside surprise.
Where TrendMatrix's rating stands now
TrendMatrix currently rates CRD-B Sell at 5.5/10; no pre/post engine snapshot brackets this report.
2 of the last 4 quarters beat the estimate; this quarter's +35.7% surprise compares with a -6.7% four-quarter average. Next scheduled report: 2026-11-02.
What argues against it
- Quality below floor (4.0 < 4.0)
- Momentum score 4.0/10 — below 4.5 minimum
- Reward/Risk 0.6:1 at current price — below 1.5:1 minimum
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $11.29
- Price target
- $11.90
- Stop
- $10.81
- Upside to target
- +5.4%
- Reward-to-risk
- 0.6:1
The stock trades at 24.8× trailing but 10.3× forward earnings — consensus estimates already build in a substantial earnings recovery.
Model outputs from TrendMatrix’s engine as of 2026-09-17 — shown for context, not personalized investment advice.
CRD-B at TrendMatrix's latest read
For financials, the EPS print is only half the story: credit costs, reserve builds, and rate sensitivity decide how a quarter actually lands.
- Industry
- Insurance Brokers
- Market cap
- $554.0M
- P/E (fwd)
- 10.3
- P/E (ttm)
- 24.8
- 52-week range
- $8.78–$13.59
- Off 52-week high
- 16.9%
- RSI (14)
- 41
- Volume vs avg
- 0.37×
- Score today
- 5.5/10